Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Infections were more prominently associated with the development of SSA/SSB autoantibody-positive pSS (OR 2.7, 95% CI 2.0-3.5).
|
30892751 |
2019 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Mononuclear cell infiltration of exocrine glands, production of Ro/SSA and La/SSB autoantibodies, along with oral and ocular dryness, are characteristic features of primary Sjögren's syndrome (pSS).
|
31366407 |
2019 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
RF should be considered as a prognostic, but not diagnostic, factor in patients with pSS, as it is associated with more severe disease course (sicca eye symptoms, ESSDAI) and parameters (production of gammaglobulins, ANA, anti SS-A, anti-SS-B autoantibodies) indicating increased B cell activity.
|
30810912 |
2019 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Primary Sjögren's syndrome is associated with a markedly increased risk of cardiovascular disease and the presence of Ro/SSA and La/SSB autoantibodies identify the subgroup of patients carrying the highest risk.
|
31127862 |
2019 |
Primary Sjögren's syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Detection of SSA and SSB Antibodies Associated with Primary Sjögren's Syndrome Using Enzyme-Linked Immunosorbent Assay.
|
30539582 |
2019 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
The comparison between the aminoacid sequence of mannan of S. cerevisiae and well characterised auto-antigens peculiar to pSS (52kD and 60kD Ro/SSA, La/SSB) was performed with the Basic Local Alignment Search Tool (BLAST).
|
28664835 |
2018 |
Primary Sjögren's syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The constellation of these findings and subsequent positive anti-SSA/SSB levels confirmed her diagnosis of primary Sjögren's syndrome (PSS).
|
28148578 |
2017 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
In pSS, functional LILRA3 was specifically associated with leucopenia (p=4.39×10(-4), OR=3.25), anti-Ro/SSA-positive subphenotypes (p=4.54×10(-3), OR=2.34) and anti-La/SSB-positive subphenotypes (p=0.012, OR=2.49).
|
24906639 |
2015 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
|
26201309 |
2015 |
Primary Sjögren's syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The increased Ro/SSA 60 and La/SSB mRNA expression in MSG of patients with pSS as well as the differential Ro/SSA 60 and La/SSB protein expression in ductal cells of MSG in patients with pSS suggest that these these 2 autoantigens, but not Ro/SSA 52, are probably involved in triggering and maintaining the tissue-specific autoimmune response in pSS MSG and may contribute to the antigen-driven immune response and local autoantibody production in pSS.
|
17552056 |
2007 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
|
14872501 |
2004 |
Primary Sjögren's syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
To assess salivary gland tissues obtained from patients with primary Sjögren's syndrome (SS) for the gene expression profile of the candidate genes TNFRSF6 (Fas), TNFSF6 (FasL), SSA1 (Ro52 alpha and the splice variant Ro52 beta), SSB (La), CTLA4, PDCD1 (PD-1), and ORM2, which were selected on the basis of their putative participation in salivary gland inflammation.
|
12528117 |
2003 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Autoantigen La/SSB is molecular target of humoral autoimmunity in patients with primary Sjogren's Syndrome (pSS) and systemic lupus erythematosus (SLE).
|
12428060 |
2002 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
However, patients with the SS hallmark Ro/SS-A and La/SS-B autoantibodies showed enhancement of both p53 peptide phosphorylation (P = 0.036) and G1 cell-cycle arrest (P = 0.015) in response to gamma radiation.
|
12059992 |
2002 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our results confirm the association of the DRB1*03-DQB1*02 haplotype with SS-A/SS-B autoantibodies positive pSS and demonstrate a significant association of the HLA-A24 with the disease.
|
11423179 |
2001 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Relationship between the occurrence of anti-SSA, anti-SSB autoantibodies and HLA class II alleles from the aspect of in vitro inhibitory effect of glucocorticosteroid on the antibody-dependent cellular cytotoxicity in patients with primary Sjögren's syndrome.
|
11056762 |
2000 |
Primary Sjögren's syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The aim of this study was to investigate the expression of La/SSB mRNA in MSGs of patients with pSS.
|
10585759 |
1999 |
Primary Sjögren's syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Due to the unusual structure of the exon 1' La/SS-B mRNA, the function and the behaviour under physiological and pathophysiological conditions in tissue of patients with primary Sjögren's syndrome or Systemic Lupus Erythematosus remained obscure.
|
9115578 |
1996 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Maternal HLA antigens and antibodies to SS-A/Ro and SS-B/La. Comparison with systemic lupus erythematosus and primary Sjögren's syndrome.
|
7582692 |
1995 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Anti-SS.B/La antibodies detected by recombinant SS.B assays were found to be highly predictive of primary Sjögren's syndrome.
|
1388639 |
1992 |
Primary Sjögren's syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Anti-La (SSB) antibodies were detected in only one family member with primary SS.
|
1629820 |
1992 |